DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.

Information source: Jeevan Jyoti Hospital
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: To Investigate the Effects of Low Dose Aspirin and Low Molecular Weight Heparin in IVF Out Come

Intervention: Low molecular weight heparin (Drug); Low dose aspirin (Drug); Heparin & aspirin (Drug); NaCl (Other)

Phase: Phase 3

Status: Recruiting

Sponsored by: Dr.Vandana Bansal

Official(s) and/or principal investigator(s):
Vandana Bansal, MS DGO PhD, Principal Investigator, Affiliation: Arpit Test Tube Baby Centre, Vandana Women's Hospital, Jeevan Jyoti Hospital & Research Centre

Overall contact:
Vandana Bansal, MS DGO PhD, Phone: +91-0532-2417252, Ext: 402, Email: bansal.drvandana@gmail.com

Summary

The purpose of the study is to determine whether low-dose aspirin and low molecular weight heparin improve the implantation and pregnancy rates in patients with repeated implantation failures in IVF cycle.

Clinical Details

Official title: Effects of Low Dose Aspirin and Low Molecular Weight Heparin Cotreatment, Alone and/or in Combination on Implantation and Clinical Pregnancy Rates in Repeated Implantation Failures in IVF Cycle.

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Primary outcome: Biological pregnancy test

Secondary outcome: Fetal heart/Gestational sac

Detailed description: The investigators hypothesize that cotreatment of low dose aspirin & low molecular weight heparin may improve implantation & clinical pregnancy rates.

Eligibility

Minimum age: 19 Years. Maximum age: 35 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- Aged between 19 to 35 years;

- Basal follicle-stimulating hormone (FSH) levels of ≤8 IU/l

- Body mass index (BMI) between 19 kg/m2 and 25 kg/m2

- Presence of both ovaries; ≥2 previous IVF failures

- Good quality embryos for transfer

- Endometrial thickness between 10 mm and 14 mm

Exclusion Criteria:

- Polycystic ovary syndrome

- Endometriosis

Locations and Contacts

Vandana Bansal, MS DGO PhD, Phone: +91-0532-2417252, Ext: 402, Email: bansal.drvandana@gmail.com

Arpit Test Tube Baby Centre, Jeevan Jyoti Hospital & Research Centre, Allahabad, Uttar Pradesh 211003, India; Recruiting
Vandana Bansal, MS DGO PhD, Phone: +91-0532-2417252, Ext: 402, Email: bansal.drvandana@gmail.com
Ashwani K Bansal, MS, Phone: +91-0532-2417252, Ext: 403, Email: arpitivf@gmail.com
Vandana Bansal, MS DGO PhD, Principal Investigator
Additional Information

Starting date: August 2013
Last updated: August 15, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017